Johnson & Johnson: A Potential Beneficiary Of A Great Rotation

Johnson & Johnson (NYSE: JNJ ) (NEOE: JNJ:CA ) started this year at the same price as it started 2020. Four years of no price appreciation is hardly an attractive proposition, even with a decent dividend. This article looks at why JNJ has stagnated, andMy approach is long-term and I focus on investing in macro ideas through low risk ETFs and CEFs. I have traded stocks and currencies for nearly ten years and currently run a family fund with my partner and fellow SA contributor Andrew McElroy. I also invest i ...